Catapult Ventures

Type

Venture Capital

Status

Active

Location

Leicester, United Kingdom

Total investments

102

Average round size

1M

Portfolio companies

78

Rounds per year

4.08

Lead investments

17

Follow on index

0.22

Exits

27

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareHealth DiagnosticsRoboticsManufacturingMedical DeviceMedicalPharmaceuticalClinical Trials

Summary

Catapult Ventures appeared to be the VC, which was created in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Leicester.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Catapult Ventures, startups are often financed by South East Growth Fund & Management, Oxford Capital Partners, Spark Ventures. The meaningful sponsors for the fund in investment in the same round are Midven, Spark Ventures, South East Growth Fund & Management. In the next rounds fund is usually obtained by South East Growth Fund & Management, Oxford Capital Partners, Octopus Ventures.

Besides them, we counted 2 critical employees of this fund in our database.

Among the most successful fund investment fields, there are Pharmaceutical, Clinical Trials. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the various public portfolio startups of the fund, we may underline Abzena plc, AMR Centre, MicroBioSensor

Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2008. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2017. Opposing the other organizations, this Catapult Ventures works on 0 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistHealthcareConsumer/RetailManufacturingBiotech/Life Sciences Show 4 more
Stage focus
GeneralistPre-SeedSeedSeries ASeries B Show 1 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
102
Lead investments
17
Exits
27
Rounds per year
4.08
Follow on index
0.22
Investments by industry
  • Biotechnology (38)
  • Health Care (31)
  • Software (18)
  • Health Diagnostics (17)
  • Medical (17)
  • Show 95 more
Investments by region
  • United Kingdom (90)
  • United States (7)
  • Israel (1)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
671K
Group Appearance index
0.62
Avg. company exit year
11
Avg. multiplicator
0.41

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
CroBio 23 Apr 2024 Biotechnology, Agriculture, Farming Seed 1M England, Cheshire, United Kingdom
Key Technologies 11 Dec 2008 National Security, Industrial, Homeland Security Seed 1M England, Dudley, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.